by Eddie Bishop | Dec 1, 2020 | US & International
As a brief recap, claim 1 of Eli Lilly’s patent requires vitamin B12 + Pemetrexed disodium and claim 2 requires vitamin B12 + Pemetrexed disodium + folic binding protein. The potential infringer, Fresenius, used a composition including Pemetrexed tromethamine in...
by Eddie Bishop | Nov 1, 2020 | US & International
Snyders’ Heart Valve Patent Snyders’ patent was to an artificial heart valve that crucially can be inserted into place without removing the native damaged valve. This is explicitly stated in the description with further details of how the artificial valve...
by Alex Bajjon | Oct 1, 2020 | US & International
Paediatrics Regulation In Europe, Orphan Medicinal Products are medicinal products that are intended for the treatment of conditions that affect no more than 5 in 10,000 people in the EU. In order to incentivise the development of treatments for these rare conditions,...
by Carolyn Haywood | Aug 1, 2020 | US & International
Background Supplementary Protection Certificates (SPCs) are available under EU law to effectively compensate patent owners for some of the lost patent protection that inevitability occurs due to the time it takes to obtain marketing authorisation. Article 3 of the SPC...
by Alex Bajjon | Jul 1, 2020 | Trademarks, US & International
Background Booking.com applied to register a number of applications containing the term “booking.com”. Registration of these trade marks was initially refused by the USPTO for being generic for the services for which protection was sought (for example,...
by David Eyre | Jun 1, 2020 | Briefings, US & International
Earlier this year we reported that the European Patent Office (EPO) has stated that the requirements for being an inventor can only be fulfilled by a natural person. The United States Patent and Trademark Office (USPTO) has now considered the parallel subject matter...
Recent Comments